卧龍電驅(600580.SH):杭州研究院100%股權已過户登記至浙江凱信名下
格隆匯 4 月 6日丨卧龍電驅(600580.SH)公佈,之前公吿披露,2021年3月8日,公司、浙江卧龍國際貿易有限公司(“卧龍國貿”)(以上合稱“轉讓方”)與浙江凱信商務管理(集團)有限公司(“浙江凱信”、“受讓方”)就卧龍電氣集團杭州研究院有限公司(“杭州研究院”)100%股權交易轉讓事宜簽訂了《卧龍電氣集團杭州研究院有限公司之股權轉讓協議》。該《股權轉讓協議》已經公司八屆五次臨時董事會審議通過。
2021年4月2日,杭州研究院100%股權過户登記至浙江凱信名下,公司已收到此次股權轉讓價款共計人民幣4.15億元。此次交易已全部完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.